preliminary data on the use of sv2a as a biomarker of neurodegeneration in alzheimer’s disease
Published 2 years ago • 148 plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
1:49
nfl as a biomarker in alzheimer’s
-
5:25
drop-ad: detecting alzheimer’s disease biomarkers in a single blood spot
-
22:54
data-driven approaches improve tau-pet biomarkers in alzheimer's disease
-
3:19
prognostic blood biomarkers in the pre-clinical stages of alzheimer’s disease
-
6:13
biomarkers for early detection of alzheimer’s disease: micrornas
-
5:34
associations between predicted brain age and alzheimer’s disease biomarkers
-
0:51
decoding #alzheimer's disease : the truth behind blood #biomarkers
-
3:27
plasma nfl levels as a potential biomarker in mci and alzheimer’s disease
-
1:38
access to alzheimer’s disease diagnostic biomarkers in clinical routine
-
3:10
promise of exosomal proteins as biomarkers in alzheimer’s disease
-
4:52
important developments in dementia: biomarkers & clinical trials
-
2:24
fluid biomarkers of immune function in alzheimer’s disease
-
7:47
biomarkers for the in vivo diagnosis of alzheimer's disease
-
4:07
opportunities and challenges of biomarkers in alzheimer's disease
-
1:14
plasma tau levels and alzheimer’s disease: what’s the relationship?
-
3:17
blood biomarkers for the differential diagnosis of alzheimer’s disease in clinical practice
-
54:09
lc3-associated endocytosis: guarding against neuroinflammation & neurodegeneration
-
56:22
blood based biomarkers for dementias
-
1:02
sleep as a biomarker for neurodegenerative disorders